cology annual meeting, and
has been tested at several of the nation's leading medical centers.
TargetScan technology is developed by Envisioneering Medical Technologies
in St. Louis, under the guidance of physicians at Washington University in St.
Louis. "Traditional hand-manipulated devices allow the prostate gland to
shift, which impedes accurate biopsy and placement accuracy. By stabilizing
the prostate, physicians can now detect cancer with greater confidence," said
Robert Mills, president, Envisioneering Medical Technologies.
About Envisioneering Medical Technologies
Envisioneering Medical Technologies, based in St. Louis, Mo., is dedicated
to creating the standard for prostate cancer care by developing technology for
improving prostate cancer diagnosis and treatment precision and effectively
managing patients throughout the continuum of care. For more information
please visit http://www.envisioneeringmedical.com.
KM-0022 A
'/>"/>SOURCE Envisioneering Medical Technologies Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
Bartlett Communications Launches Free Website Evaluation Tool for Small to Mid-Sized Businesses2.
Care Improvement Plus Achieves Top Scores for First SNP Evaluation Measures3.
Best Practice Database Provides Key Findings for Biopharma Product Launch Evaluation4.
Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter5.
VA Announces Expansion of Disability Evaluation System Pilot6.
DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation 7.
Study sees need for standardized evaluation of antibody response to HIV-18.
Hooper Holmes Announces Sale of Claims Evaluation Division9.
Syntermed licenses Emory imaging technology for improved evaluation of heart failure patients10.
Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors11.
Population Health Impact Institute Releases Methods Evaluation Process(TM) (MEP(TM)) Accreditation Standards for Public Comment Period